Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000617249 | SCV000737890 | uncertain significance | Cardiovascular phenotype | 2017-01-20 | criteria provided, single submitter | clinical testing | The p.T209M variant (also known as c.626C>T), located in coding exon 1 of the KCND3 gene, results from a C to T substitution at nucleotide position 626. The threonine at codon 209 is replaced by methionine, an amino acid with some similar properties. This amino acid position is not well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Revvity Omics, |
RCV003129942 | SCV003813996 | uncertain significance | not provided | 2020-11-25 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV005091773 | SCV005835201 | likely benign | Spinocerebellar ataxia type 19/22 | 2024-12-12 | criteria provided, single submitter | clinical testing |